Floatz logo

Sotagliflozin

Chemotherapy

Icahn School of Medicine at Mount SinaiSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

1411 Active assets in the Chemotherapy cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
Vitamin B6
M.D. Anderson Cancer Center
Phase 4BB
Inno-206
M.D. Anderson Cancer Center
Phase 2BB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB
PROPOFOL
Hong Kong Children's Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Sotagliflozin is also rated in:

cardiomyopathy due to anthracyclinesDormant
CCC
Indicative ·
53 / 100
View asset →
heart disorderDormant
CCC
Indicative ·
53 / 100
View asset →
lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →